ISPY1 Dataset Clause Samples
POPULAR SAMPLE Copied 1 times
ISPY1 Dataset. This dataset contains the clinical and MRI data from the ISPY1 clinical trial of patients with breast cancer2. The goal of this project was to improve the prediction of clinical outcomes to neoadjuvant chemotherapy in patients with breast cancer. Currently, most patients with breast cancer undergo neoadjuvant chemotherapy, which is aimed to reduce the tumor size (burden) before surgery to remove the tumor or the entire breast. Some of the patients response completely to the therapy and the patient does not present any residual tumor at the time of surgery. On the other hand, some patients have residual disease at the time of surgery and further treatment is required. Dataset Name ISPY1_Trial Owner organization This shared data set was provided by ▇▇▇▇▇ ▇▇▇▇▇▇, PhD and ▇▇▇▇ ▇▇▇▇▇▇, PhD from the Breast Imaging Research Program at UCSF, in collaboration with ▇▇▇▇▇, CALGB, the I-SPY TRIAL, and TCIA. Dataset description (informal meta-data) The dataset includes data about 222 patients treated for breast cancer including demographics, clinical measures and outcomes It is a dataset that was already available when the BOUNCE project started. The data will be explored for their potential to be used in the project for building an in-silico model for resilience prediction. Formal Meta-data There is a data dictionary available for the various columns used. Standards No specific standards have been followed. Origin The I-SPY TRIAL Language The data are numeric Size 13 KB Variety Fully structured Type Numeric Format Tabular format Velocity 1 CSV/XLS file 2 ▇▇▇▇▇://▇▇▇▇.▇▇▇▇▇/▇▇▇▇▇/ispy-1-trial Storage A copy of the data is available at the BOUNCE data infrastructure Quality High quality data, will not many missing values. In addition a quality and consistency check has already been performed by the owning institution. Example ▇▇▇▇▇://▇▇▇▇.▇▇▇▇▇/▇▇▇▇▇/ispy-1- trial/workspace/file?filename=clean_data_ISPY-1_clinica.csv Availability The whole dataset is available to the public through their download site. Through the BOUNCE platform, the data will not be made available to external entities. Availability after the end of the project The data will be available after the end of the BOUNCE project both internally in the BOUNCE platform for consortium members and through the original dataset’s website. Sharing mechanisms Data are accessible through the original data web site. Within BOUNCE data are accessible through the Data Access API by all partners for downloading, viewing,...
ISPY1 Dataset. This dataset contains the clinical and MRI data from the ISPY1 clinical trial of patients with breast cancer6. The goal of this project is to improve the prediction of clinical outcomes to neoadjuvant chemotherapy in patients with breast cancer. Currently, most patients with breast cancer undergo neoadjuvant chemotherapy, which is aimed to reduce the tumor size (burden) before surgery to remove the tumor or the entire breast. Some of the patients response completely to the therapy and the patient does not present any residual tumor at the time of surgery. On the other hand, some patients have residual disease at the time of surgery and further treatment is required. Table 9 presents the various fields of the dataset. Age Patient Age Numeric Race_id Patient Race 1=Caucasian 3=African American 4=Asian 5=Native Hawaiian/Pacific Islander 6=American Indian/Alaskan Native 50=Multiple race ERpos Estrogen Receptor Status (▇▇▇▇▇▇ 0=Negative Score or Community 1=Positive determined), pre-treatment 2=Indeterminate PgRpos Progesterone Receptor Status 0=Negative (▇▇▇▇▇▇ Score or Community 1=Positive determined), pre-treatment 2=Indeterminate HR Pos Hormone Receptor Status, pre- treatment 0=Negative for both ER and PR 1=Positive if either ER or PR was Positive 2=Indeterminate if both ER and PR were Indeterminate Her2MostPos Her2 Status, pre-treatment, 0=Negative (replaced Her2CommPos, adding in Central Her2 IHC results for missing Community 1=Positive Blank= indeterminate or 4/6/2016) Status not done 6 ▇▇▇▇▇://▇▇▇▇.▇▇▇▇▇/▇▇▇▇▇/ispy-1-trial HR_HER2_CATEGORY 3-level HR/Her2 category pre- 1=HR Positive, Her2 treatment Negative 2=Her2 Positive 3=Triple Negative HR_HER2_STATUS 3-level HR/Her2 status pre- treatment HRposHER2neg = HR Positive, Her2 Negative HER2pos = Her2 Positive TripleNeg =Triple Negative BilateralCa Does the patient have bilateral 0=No breast cancer prior to 1=Yes neoadjuvant therapy? Laterality Index Tumor Laterality: 1=Left 2=Right MRI LD: LD spans all disease present (inv & DCIS) even if there is intervening normal tissue Numeric (in mm) Baseline Timepoint 1= baseline Numeric 1-3d AC Timepoint 2= 1-3days after start of AC Numeric InterReg Timepoint 3= Inter-regimen Numeric PreSurg Timepoint 3= Inter-regimen Numeric SUBJECTID I-SPY ID de-identifies a patient’s CALGB and ACRIN ID Numeric DataExtractDt Date clinical data was downloaded from the CALGB database Date format Sstat Survival Status 7=A...
